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ABSTRACT 
The incidence of metabolic syndrome is rising at an unprecedented pace. The technological advancements, lifestyle changes and mechanization are 
all considered responsible for this rising global health issue. Nature-derived phytochemicals possess several unique properties that may be 
usefulformanagement of metabolic syndrome. Mangiferin, present in various plant species, has been shown to have anti-obesity, anti-diabetic, anti-
oxidant and anti-inflammatory properties. Mangiferin also modulates glucose and lipid metabolisms and restores glucose and lipid homeostasis.  
In this review, we attempt to provide the latest information available on mangiferin and its effects on various biological processes 
associated/implicated in metabolic syndrome.  
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INTRODUCTION 
Metabolic syndrome is a constellation of closely associated disorders 
whose common root cause is the sedentary lifestyle, intake of 
calorie-rich diet, reduced physical activity sleep deprivation and 
stress. This group of symptoms comprises of obesity, type 2 diabetes 
mellitus, insulin resistance and hyperglycemia, hypertension, non-
alcoholic fatty liver disorder, cardiovascular disorders and 
dyslipidemia [1]. One of the principal causes behind metabolic 
syndrome is obesity. The obesity epidemic represents a serious public 
health concern due to its increasing incidence and associated risk 
profile for several diseases and consequent morbidity and mortality. A 
recent report by the WHO states that globally 39% of adults aged 18 
and over, were overweight in 2014, and 13% were falling under the 
obese category [2]. 
Natural compounds and herbs have been traditionally used to treat 
and cure various disorders associated with imbalanced metabolism. 
Based on the fact that plants have been used to manage human 
health for more than 3000 y, and that they are easily available to 
local populations, use of plant derived herbal products for the 
management of obesity, and diabetes is an attractive and promising 
area of research. Ancient Ayurvedic texts describe several herbs and 
herbal extracts for treatment of obesity and associated metabolic 
syndrome. Various studies have described the benefits of using plant 
extracts for treatment of obesity, insulin resistance, type 2 diabetes, 
and polycystic ovary syndrome in obese individuals [3-6].  
In the present review, we summarize the therapeutic potential of 
one such molecule, mangiferin, for treatment of metabolic syndrome 
as it modulates several biological processes related to energy 
generation, energy expenditure and metabolism.  
Chemical properties and occurrence of mangiferin 
Mangiferin is a naturally-occurring polyphenol of C-
glycosylxanthone structure with diverse pharmacological actions. 
Mangiferin is widely present in higher plants. It is present in higher 
concentration in Mangifera indica, Cyclopia and Salacia species. 
Mangiferin has been reported to possess analgesic, anti-diabetic, 
anti-sclerotic, antimicrobial, antiviral, cardio-, hepato-, and neuro-
protective, anti-inflammatory and anti-allergic properties. It is sold 
for treatment of metabolic disorder in Cuba under the trade name of 
Vimang [7, 8]. The presence of catechol moiety containing four 
hydroxyl groups makes mangiferin an efficient anti-oxidant and 
anti-free radical molecule [8, 9]. Mangiferin is poorly soluble in 
aqueous solutions. Solubility and intestinal permeability of 
mangiferin is found to be increased through its complexation with 
phospholipids enhancing the bioavailability by 2.3 times compared 
with crude mangiferin in experimental rats [10]. Complexation of 
mangiferin with β-cyclodextrin also improves thermal stability and 
water solubility of mangiferin revealing the potential usefulness of 
mangiferin derivatives in preparation of novel thermally stable 
formulations [11].  
 
 
Fig. 1: Structure of mangiferin 
 
Mangiferin ameliorates obesity and associated metabolic 
syndrome 
Onset of metabolic syndrome disrupts the homeostatic balance 
between various organs such as the liver, pancreas, heart, brain, 
adipose tissue and various other regulatory cells throughout the 
body [1]. Herbal extracts of Mangifera indica whose principle 
component is mangiferin have been shown to counteract 
obesity/metabolic syndrome. It has been demonstrated that 1% 
mango seed kernel extract in hot water (MESK-W) prevented weight 
gain and liver steatohepatitis in ahigh fat diet treated mice [12]. 
Kobayashi et al. have shown that in 3T3-L1 adipocytes, 1% MESK-W 
inhibited cellular lipid deposition by reducing glycerol 2-phosphate 
dehydrogenase activity and PPARγ and C/EBPα expression levels 
[12]. Moreno et al. have shown that ethanolic extract of Mangifera 
indica from both stem bark and leaves inhibitthe action of pancreatic 
lipase, and lipoprotein lipase, reduce fat absorption and increase 
fecal fat excretion. Moreover, Mangifera indica extract down-
regulated the expression of several genes associated with the 
pathophysiology of obesity and inflammation such as lipoprotein 
lipase, hormone-sensitive lipase, fatty acid synthase and resistin in 
liver and epididymal fat [13]. Moreover, it was found to decrease the 
expression DGAT2, SREBP-1c, ACC genes, and up-regulated CD36, 
PPAR-α, CPT-1 expression and prevented fat deposition in visceral 
fat pad and liver [14, 15]. Similar studies in our lab have proven that 
ethanolic extract of Mangifera indica seed kernel prevented weight 
gain in diet-induced obese mice, which was comparable with 
standard anti-obesity drug Orlistat [16]. The inflammatory response 
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by the body is generally helpful in removing viruses, bacteria and 
other pathogens and is a crucial element of the innate immune 
system. Increased number of white blood cells, higher plasma 
concentrations of pro-inflammatory markers like TNF-α, certain 
interleukins, IFN-γ, C-reactive protein, adhesion molecules and E 
and P selectins are indicators of systemic inflammation. Moreover, 
higher insulin and decreased leptin and adiponectin levels are also 
considered markers of inflammation [17]. It has been shown by 
several investigators that “chronic-low grade inflammation” triggers 
metabolic syndrome and this continuing systemic inflammatory 
milieu upsets the delicately balanced intricate metabolic pathways. 
In obesity, this inflammatory state becomes “chronic” due to the 
consistent release of pro-inflammatory cytokines, whose major 
source is classically activated macrophages (M1 phenotype) present 
in inflated adipose tissue [18].  
As inflammation and ensuing oxidative stress forms a critical part of 
metabolic syndrome, reducing pro-inflammatory milieu holds a 
promising strategy to manage metabolic syndrome. Pro-
inflammatory cytokines such as IL-1 impair insulin signaling by 
reducing the expression of Insulin Receptor Substarte-1 (IRS-1) and 
markedly inhibiting GLUT-4 translocation to the plasma membrane 
[19]. TNF-α is an adipokine having potent inflammatory activity. It is 
over-expressed in obesity and considered to be one critical factor 
involved in progression of obesity associated diabetes mellitus [20]. 
The anti-inflammatory activity of mangiferin is attributed to its 
inhibitory action on potent inflammatory pathway NF-κβ and pro-
inflammatory cytokines Interleukin-1 and TNF-α [21].  
Inducible-nitric-oxide synthase (iNOS) plays a major role in obesity-
induced insulin resistance. Shinozaki et al. have demonstrated that 
over-expression of iNOS in the liver induces hepatic insulin 
resistance in experimental mice [22]. It has been shown that 
mangiferin decreased the mRNA levels of iNOS, TNF-α and increased 
the expression of TGF-β. Moreover, it also reduced levels of (iNOS) 
and cyclooxygenase-2, which are required in the synthesis of 
inflammatory mediators [23]. These findings suggest that 
mangiferin can be a valuable tool for the treatment of inflammation, 
cancer, autoimmune disorders, atherosclerosis and coronary heart 
disease [24]. Mangiferin can be used to treat sepsis as it inhibits pro-
inflammatory NF-kB pathway and up regulates heme oxygenase-1 
expression in the lungs [25]. Mangiferin treatment in Wistar rats 
reduced neuro-inflammation and brain oxidative damage by 
reducing glucocorticoids, IL-1β, NF-κB, TNF-α, and its receptor TNF-
R1 levels in plasma. Bhatia et al. have demonstrated that in 
microglial cells mangiferin inhibits LPS induced synthesis of 
prostaglandin E2 and COX-2, and reduced the pro-inflammatory milieu 
in the brain. However, mangiferin did not affect the expression of iNOS 
and TNF-α in activated microglial cells. Taken together, mangiferin 
reduces cerebral damage owing to its potent anti-inflammatory and 
anti-oxidant properties [26]. In murine activated macrophages 
mangiferin inhibited the expression of RelA/RelB thus preventing the 
activation of NF-kβ signaling cascade. Additionally, it inhibited a large 
array of genes, which are crucial in regulation of apoptosis, 
inflammation and body homeostasis (fig. 3) [21].  
Mangiferin ameliorates oxidative stress 
Generation of reactive oxygen species leads to cellular membrane 
damage and is implicated in the pathology of obesity, diabetes, 
atherosclerosis and cardiovascular disorders. Obesity is 
characterized by systemic increase in reactive oxygen species 
levels,which are known to reduce insulin sensitivity [27]. Mangiferin 
has been shown to possess higher free radical scavenging capacity, 
and the ferric reducing ability of plasma (FRAP) compared with 
other anti-oxidants such as L-ascorbic acid and Trolox, a vitamin E 
analog. Human Umbilical Vein Endothelial Cells (HUVEC) treated 
with mangiferin showed significantly higher survival under 
hydrogen peroxide induced oxidative stress [28].  
Elevated levels of free radicals and reactive oxygen species promote 
development of various pathophysiological conditions associated 
with diabetes mellitus. Diabetics have been reported to suffer with 
heightened oxidative stress due to increased activity of polyol and 
hexosamine pathways, higher advanced glycation end product and 
increased expression of AGE receptors [29]. Diabetics have been 
found to have higher oxidation of plasma proteins and reduced free 
radical scavenging ability compared to healthy controls [30]. 
Diabetes is also characterized by decreased activities of anti-oxidant 
enzymes such as superoxide dismutase (SOD) and catalase (CAT) 
and increased malondialdehyde, advanced oxidation protein 
products and protein carbonyls [31]. In a rat model for 
galactosamine induced hepatic pathophysiology mangiferin exerted 
hepatoprotective activity by reducing oxidative stress and 
consequent cellular damage by inhibiting NF-kB pathway and 
enhancing cellular anti-oxidant defense via the Nrf-2 pathway [32]. 
Oral administration of mangiferin in STZ induced diabetic rats 
decreased blood glucose and increased plasma insulin levels [33]. It 
has been observed that mangiferin administration significantly 
increased the levels SOD, CAT and glutathione peroxidase and 
treatment with mangiferin also prevents cellular membrane damage 
by reducing lipid peroxidation [33].  
 
 
Fig. 2: Therapeutic effects of mangiferin 
 
 
Fig. 3: Inhibition of inflammatory genes by mangiferin  [21] 
 
Mangiferin in treatment of diabetes 
Diabetes is characterized by hyperglycemia, defects in cellular 
uptake of glucose due to decreased insulin sensitivity and increased 
gluconeogenesis in the liver. Hyperglycemia in diabetics is attributed 
to decreased insulin sensitivity in insulin target organs like muscles, 
liver and adipose tissue. Improper utilization of glucose in key 
glucose utilizing pathway leads to hyperglycemia. Other key 
mechanisms contributing to hyperglycemia is higher hepatic out-put 
of glucose due to increased activity of gluconeogenesis pathway.  
Mangiferin promotes glucose utilization by increasing its cellular 
uptake. It has been shown that Salacia oblonga extract, whose main 
active component is mangiferin, increased glucose uptake by 50% in 
rat myotubes and 3T3-L1 adipocytes. At 1 mM,mangiferin increased 
glucose utilization by two folds in 3T3-L1 cell lines compared to 
untreated controls [34]. The increased cellular uptake of glucose is 
attributed to the enhanced surface expression of GLUT4 
transporters [35]. In a dose-dependent manner mangiferin down-
regulates the expression of key gluconeogenesis pathway enzyme 
namely fructose-1,6-bisphosphatase (FBP). Inhibition of 
gluconeogenesis in the liver reduces hepatic glucose production and 
thus reduces blood-glucose levels [36]. 
Periyar et al. have demonstrated that in STZ-induced diabetic mice 
mangiferin treatment increased the activity of glycolytic and 
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glycogen synthesis pathways, while decreased gluconeogenesis [37]. 
Ethanolic extract of Mangifera indica has been shown to inhibit α-
glucosidase activity in vitro making mangiferin a potential treatment 
agent against obesity and diabetes [38]. Complex carbohydrate 
molecules are broken down into glucose in the gut by a glucosidase 
class of enzymes such as sucrase, isomaltase and maltase. 
Mangiferin has also been shown to reduce glucose absorption 
through its inhibitory effect on α-glucosidase enzymes in 
experimental rats. This extra pancreatic action of mangiferin 
reduces glucose absorption and subsequent rise in blood-glucose 
levels [39]. It has been established that mangiferin derivatives 
inhibit protein tyrosine phosphatase1B (PTP1B) activity and PTP1B 
inhibition is considered to be a potential target for treatment of 
diabetes mellitus [40].  
It has been shown that 40 mg/kg body weight mangiferin is anti-
hyperglycemic in STZ induced diabetic rats by enhancing insulin 
secretion and activities of key enzymes of carbohydrate metabolism 
[41]. This dose reduced pancreatic β-cell damage, regenerated 
insulin secreting β-cells, and improved non-enzymatic, anti-oxidant 
status in STZ induced diabetic mouse thus protecting the mouse 
against diabetes [42]. At the same dose mangiferin treatment 
significantly reduced several other parameters such as blood 
glucose, urea, uric acid, creatinine and enzymes like AST, ALT and 
ALP in STZ induced diabetic rats [43].  
Chronic treatment with mangiferin significantly ameliorated renal 
dysfunction in diabetic rats, as evidenced by a decrease in kidney 
damage markers like albuminuria and blood urea nitrogen. 
Moreover, mangiferin treatment caused substantial increases in 
glyoxysylase-1 enzymatic activity, glutathione levels and reduced 
the levels of advanced glycation end products, lowered lipid 
peroxidation and reduced malondialdehyde in the kidney of diabetic 
rats [44]. Methanolic extracts of Mangifera indica reduced the levels 
of glycated hemoglobin by 20.78% and 27.33% after 14 and 21 d 
treatment respectively compared with non-treated animals [45]. 
Esterified-derivatives of mangiferin have proven to be potent 
hypoglycemic molecules as compared to mangiferin itself. The lipid 
solubility and islet protective effects of esterified-derivatives were 
also found to be stronger than crude mangiferin [46]. 
 
Table 1: Physiological effect of mangiferin on effector organs (1) Liver (2) Brain (3) Intestine (4) Adipose (5) Pancreas (6) Macrophages 
and (7) Kidney 
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 GLUT4 activity 
 Glucose utilization 
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Blood urea nitrogen 
Glutathione 




In summary, natural compounds and herbs, parts of Indian traditional 
knowledge have been consistently used by humans for treatment of 
various health conditions. Ancient knowledge and modern science can 
be combined to produce novel drug molecules for treatment of 
metabolic disorders. Mangiferin, isolated from various plants, is one 
such bioactive compound, which has been found to modulate various 
pathways and processes associated with metabolism, oxidative stress 
and inflammation. It reduces inflammation by inhibiting synthesis of 
key inflammatory cytokines and reduces oxidative stress by 
strengthening the anti-oxidant capacity of the body. Mangiferin is a 
potent anti-hypoglycemic molecule as it inhibits absorption of glucose 
from the gut, promotes cellular glucose uptake, enhances the activity 
of glycolytic enzymes and inhibits gluconeogenesis. Mangiferin also 
reduces damage to kidneys, liver and could be a potential lead 
molecule for further development as a potent anti-obesity, anti-
diabetic and anti-inflammatory molecule.  
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